PUBLICATIONS

Transkript

1 PUBLICATIONS 2015 Journath G, Hammar N, Elofsson S, Linnersjo A, Vikstrom M, Walldius G, Lindgren P et al. Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden. PloS one. 2015; 10(11):e Landfeldt E, Mayhew A, Eagle M, Lindgren P, Bell CF, Guglieri M, et al. Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self- Assessment Tool (DMDSAT). Neuromuscul Disord. 2015; 25(12): Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, et al. Compliance to Care Guidelines for Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases. 2015; 2(1): Gralén K, Andersson E, Ahlberg I, Steen Carlsson K & Olofsson S Hemtjänst, vård- och omsorgsboende eller mitt emellan? Ett kunskapsunderlag för planeringen av morgondagens äldreomsorg Stockholm: Myndigheten för vård- och omsorgsanalys, Rapport 2015:8 Olofsson S, Gralén K, Ahlberg I & Persson U Värdet av färre administrationstillfällen för personer med multipel skleros (MS) som behandlas med injektionsläkemedel. En betalningsviljestudie Lund: IHE Rapport 2015:2 Kjellsson G, Gerdtham UG & Petrie D Lies, Damned Lies, and Health Inequality Measurements: Understanding the Value Judgments. Epidemiology Sep; 26(5): Hansen F, Anell A, Gerdtham UG & Lyttkens CH The Future of Health Economics: The Potential of Behavioral and Experimental Economics Nordic Journal of Health Economics, Gerdtham UG, Lundborg P, Lyttkens CH & Nystedt P Do Education and Income Really Explain Inequalities in Health? Applying a Twin Design Scandinavian Journal of Economics. Berg J, Lindgren P, Mejhert M, Edner M, Dahlström U & Kahan T Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry Value Health Jun; 18(4):

2 Ragnarson Tennvall G., Norlin J.M., Malmberg I., Erlendsson A.M. & Hædersdal M. Health related quality of life in patients with actinic keratosis an observational study of patients treated in dermatology specialist care in Denmark Health and Quality of Life Outcomes 2015; 13(111): 1-9 Persson U & Jönsson B The End of the International Reference Pricing System? Appl Health Econ Health Policy. Publicerad online: 26 juni 2015 Ragnarson Tennvall G & Lundqvist A Screening för livmoderhalscancer. Rekommendation och bedömningsunderlag. Bilaga: Värdet av populationsbaserad screening för livmoderhalscancer. Hälsoekonomisk analys av HPV-test och cytologi Stockholm: Socialstyrelsen, Artikelnummer: Öien RF, Forsell H & Ragnarson Tennvall G Cost consequences due to reduced ulcer healing times analyses based on the Swedish Registry of Ulcer Treatment Int Wound J Pickwell K, Siersma V, Kars M, Apelqvist J, Bakker K, Edmonds M, Holstein P, Jirkovská A, Jude E, Mauricio D, Piaggesi A, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J & Schaper N Predictors of lower-extremity amputation in patients with an infected diabetic foot ulcer Diabetes Care. 2015; 38: Steen Carlsson K, Andersson E, Lundqvist A & Willis M PÅVERKBARA KOSTNADER FÖR TYP 2-DIABETES ÅR 2020 OCH ÅR 2030 I SVERIGE. Prognoser med IHE Cohort Model of Type 2 Diabetes Lund: IHE Rapport 2015:1 Neslusan C, Teschemaker A, Johansen P, Willis M, Valencia-Mendoza A & Puig A Cost-Effectiveness of Canagliflozin versus Sitagliptin as Add-on to Metforminin Patients with Type2 Diabetes Mellitus in Mexico Value in health regional issues 2015; 8C: 8-19 Jönsen A, Bengtsson AA, Hjalte F, Petersson IF, Willim M & Nived O Total cost and cost predictors in systemic lupus erythematosus - 8-years follow-up of a Swedish inception cohort Lupus Oct;24(12): Hofmarcher T & Borg S Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden Journal of Medical Economics. 2015; 18(7):

3 Baghaipour MR & Steen Carlsson K Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies Eur J Haematol Feb; 94 Suppl 77: 30-7 Hjalte F, Steen Carlsson K & Schmitt-Egenolf M Real-World Outcome Analysis of Continuously and Intermittently Treated Patients with Moderate to Severe Psoriasis after Switching to a Biologic Agent Dermatology Publicerad online 20 februari 2015 Steen Carlsson K, Hjalte F, Lundqvist A, Ragnarson Tennvall G, Häger Glenngård A, Nilsson S & Lundgren C medverkan i Nationella riktlinjer Diabetesvård Stöd för styrning och ledning Stockholm: Socialstyrelsen, Artikelnummer: Norlin J, Steen Carlsson K, Persson U & Schmitt-Egenolf M Resource Use in Patients with Psoriasis After the Introduction of Biologics in Sweden Acta Derm Venereol 2015; 95: Norrlid H, Dahm P & Ragnarson Tennvall G Evaluation of the cost-effectiveness of buprenorphine in treatment of chronic pain using competing EQ-5D weights Scandinavian Journal of Pain 2015; 6: PUBLICATIONS 2014 Kiadaliri AA, Gerdtham UG, Eliasson B & Carlsson KS Cost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in sweden. Diabetes Ther Dec; 5(2): Epub 2014 Sep 12 Olofsson S & Hjalte F Samhällets kostnader för utbrottet av pandemisk influensa A(H1N1) 2009/2010 MSB - Myndigheten för samhällsskydd och beredskap Publikationsnummer MSB795-December 2014 Borg S, Palaszewski B, Gerdtham U-G, Ödegaard F, Roos P and Gudbjörnsdottir S Patient-Reported Outcome Measures and Risk Factors in a Quality Registry: A Basis for More Patient- Centered Diabetes Care in Sweden International Journal of Environmental Research and Public Health 2014, 11, Lundqvist A, Steen Carlsson K, Johansen P, Andersson E & Willis M Validation of the IHE Cohort Model of Type 2 Diabetes and the Impact of Choice of Macrovascular Risk Equations PLOS ONE 2014; 9(10):

4 Lökk J, Olofsson S & Persson U Willingness to pay for a new drug delivery in Parkinson patients Journal of Multidisciplinary Healthcare 2014; 7: Ida Ahlberg KOSTNADER FÖR RÖRELSEORGANENS SJUKDOMAR I SVERIGE ÅR 2012 Lund: IHE Rapport 2014:4 Romé Å, Persson U, Ekdahl C & Gard G Costs and outcomes of an exercise referral program - a 1-year follow-up study European Journal of Physiotherapy 2014; Early Online: 1-11 Vataire A-L, Aballéa S, Antonanzas F, Hakkaart- van Roijen L. Lam R, McCrone P, Persson U & Toumi M Core Discrete Event Simulation Model for the Evaluation of Health care Technologies in Major Depressive Disorder Value in Health 01/2014, 17(2): Saulyte Trakymiene S & Steen Carlsson K On-demand treatment in persons with severe haemophilia Eur J Haematol Suppl Aug;76:39-47 Ohm L, Lundqvist A, Dickman P, Höglund M, Persson U, Stenke L, Steen Carlsson K & Björkholm M Real-world cost-effectiveness in chronic myeloid leukaemia: The price of success during four decades of development from non-targeted treatment to imatinib Leuk Lymphoma, 2014 Aug 20:1-16. Borg S, Näslund I, Persson U & Ödegaard K Obesity and Surgical Treatment - A Cost-Effectiveness Assessment for Sweden Nordic Journal of Health Economics 2014 Löfvendahl S, Theander E, Svensson Å, Steen Carlsson K, Englund M & Petersson IF Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden - a population-based register study PLOS ONE 2014; 9(5): 1-10 Hoogendoorn M, Feenstra TL, Asukai Y, Borg S, Hansen RN, Jansson S-A, Samyshkin Y, Wacker W, Briggs AH, Lloyd A, Sullivan SD & Rutten-van Mölken MPMH Cost-effectiveness models for chronic obstructive pulmonary disease (COPD): cross-model comparison of hypothetical treatment scenarios Value Health, 2014 Jul; 17(5): Norlin JM, Schmitt-Egenolf M, Steen Carlsson K, & Persson U Registerstudier mäter effektivitet av läkemedel I klinisk praxis. Exemplet PsoReg omfördelning av systemisk terapi kan ge ökad effektivitet Läkartidningen, 2014 Jun 11-17; 111(24): Steen Karlsson K & Persson U Cost-effectiveness of add-on treatments to metformin in a Swedish setting: liraglutide vs sulphonylurea or sitagplitin Journal of Medical Economics. Posted online on June 26,

5 Edited by Anthony J Culyer and Gisela Kobelt PORTRAIT OF A HEALTH ECONOMIST, ESSAYS BY COLLEAGUES AND FRIENDS OF BENGT JÖNSSON IHE, Lund, Sweden 2014 Persson U Cost-Benefit Analysis and the use of individual s willingness-to-pay for health improvements in the health care In PORTRAIT OF A HEALTH ECONOMIST, ESSAYS BY COLLEAGUES AND FRIENDS OF BENGT JÖNSSON Edited by Anthony J Culyer and Gisela Kobelt. IHE, Lund, Sweden Ragnarson Tennvall G, Hjalte F & Lundqvist A medverkan i Nationella riktlinjer Bröst-, prostata-, tjocktarms- och ändtarmscancervård Stöd för styrning och ledning Stockholm: Socialstyrelsen, Artikelnummer: Norlin JM, Steen Carlsson K, Persson U & Schmitt-Egenolf M Resource Use in Patients with Psoriasis After the Introduction of Biologics in Sweden Acta Derm Venereol. Kiadaliri AAK, Gerdtham U-G, Nilsson P, Eliasson B, Gudbjörnsdottir S & Steen Carlsson K Health Utilities of Type 2 Diabetes-Related Complications: a Cross-Sectional Study in Sweden Int J Environ Res Public Health, 2014 May 7; 11(5): Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovská A, Mauricio D, Tennvall GR, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J & Schaper NC. Health-Related Quality of Life predicts major amputation and death, but not time to healing, in people with diabetes mellitus presenting with foot ulcers: the Eurodiale study Diabetes Care 2014; 37(3): Willis M, Erntoft S, Persson S, Norlin J, Persson U Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting Journal of Health Economics and Outcomes Research 2014; 2(1): 1-14 Hofmarcher T, Jönsson B & Wilking N Access to high-quality oncology care across Europe Lund: IHE Report 2014:2 Kjellsson G & Gerdtham U-G Measuring health inequalities using the concentration index approach. Kapitel i Encyclopedia of Health Economics, 1st Edition. Encyclopedia of Health Economics, Vol 2. Editor in Chief: A J Culyer San Diego: Elsevier April 2014 pp Burström K, Sun S, Gerdtham U-G, Henriksson M, Johannesson M, Levin L-Å & Zethraeus N Swedish experience-based value sets for EQ-5D health states Quality of Life Research, 2014; 23: Olofsson S & Persson U Värdet av ett nytt sätt att administrera levodopa Lund: IHE Rapport 2014:1 5

6 Garmy P, Jakobsson U, Steen Carlsson K, Berg A & Clausson EK Evaluation of a School-Based Program Aimed at Preventing Depressive Symptoms in Adolescents Journal of School NursinG. Online Feb 2014 PUBLICATIONS 2013 Jönsson B & Steen Carlsson K Värdet av läkemedel Stockholm: SNS Förlag November 2013 Gerdtham U G & Lyttkens C H Vad kostar ojämlikhet i hälsa? (Och varför vill vi veta det?) Läkartidningen 2013; 110(47): 2124 (Debatt) Ljungvall Å, Gerdtham U G & Lindblad U Misreporting and misclassification: implications for socioeconomic disparities in body-mass index and obesity The European Journal of Health Economics.This article is published with open access at Springerlink.com December 2013 Nordin M & Gerdtham U G Why a positive link between age and income-related health inequality? Nordic Journal of Health Economics November 2013 Saha S & Gerdtham U G Cost of illness studies on reproductive, maternal, newborn, and child health: a systematic literature review Health Economics Review 2013, 3:24 Dahlrup B, Nordell A, Steen Carlsson K & S Elmståhl S Health Economic Analysis on a Psychosocial Intervention for Family Caregivers of Persons with Dementia Dement Geriatr Cogn Disord 2013; 37: Saha S, Steen Carlsson K, Gerdtham U G, Eriksson M K, Hagberg L, Eliasson & Johansson P Are Lifestyle Interventions in Primary Care Cost-Effective? An Analysis Based on a Markov Model, Differences-In-Differences Approach and the Swedish Björknäs Study PLoS ONE 8(11): e80672, 2013 Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovská A, Mauricio D, Tennvall GR, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J & Schaper NC. Health-Related Quality of Life predicts major amputation and death, but not time to healing in people with diabetes mellitus presenting with foot ulcers - the Eurodiale study. Diabetes Care Oct 29. [Epub ahead of print] Andersson B, Appelgren B, Sjödin V, Ansari D, Nilsson J, Persson U, Tingstedt B & Andersson R Acute pancreatitis - costs for healthcare and loss of production Scandinavian journal of gastroenterology (Impact Factor: 2.08). 10/2013 Posted online on October 16,

7 Glenngård AH Objectives, actors and accountability in quasi-markets: Studies of Swedish primary care Doktorsavhandling Lund: Lunds universitet, Ekonomihögskolan. Lilje S, Persson U, Tessem Tangen S, Kåsamoen S & Skillgate E Costs and utilities of manual therapy and orthopedic standard care for low prioritized orthopedic outpatients of working age: A cost consequence analysis Clinical Journal of Pain (Forthcoming) Hjalte F & Olofsson S SAMHÄLLETS KOSTNADER FÖR ATT FÖREBYGGA DRUNKNINGSOLYCKOR Delprojekt i kostnaderna av samhällets säkerhetsarbete Lund: IHE Rapport 2013:1 Burström K, Sun S, Gerdtham U-G, Henriksson M, Johannesson M, Levin L-Å & Zethraeus N Swedish experience-based value sets for EQ-5D health states Quality of Life Research, Published online 22 August Fischer K, Steen Carlsson K, Petrini P, Holmström M, Ljung R, van der Berg H M and Berntorp E Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s Blood, 2013; 122(7): Anell A & Glenngård AH Vad gör primärvården för äldre med komplexa behov? Arbetssätt och samverkan vid åtta mottagningar i Region Skåne samt implikationer för landsting och kommuner Stockholm: Leading Health Care, Willis M, Asseburg C & He J Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM) Journal of Medical Economics 2013; 16(8): Ghatnekar O, Andersson R, Svensson M, Persson U, Ringdahl U, Zeilon P and Borrebaeck Carl AK Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature International Journal of Cancer, Online 6 May 2013 Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J and Schaper NC Importance of factors determining the low health-related quality of life in people presenting with a diabetic foot ulcer: the Eurodiale study Diabetic Medicine 2013 Glenngård AH Productivity and patient satisfaction in primary care Conflicting or compatible goals? Health Policy 2013 Kjellsson G and Gerdtham U-G Lost in translation: rethinking the intermediate value judgment for health inequalities Research on Economic Inequality In Press 7

8 Kiadaliri AA, Jafari M and Gerdtham U-G Frontier-based techniques in measuring the hospitalists efficiency in Iran: a systematic review and meta analysis BMC Health Services Research Jarl J, Heckley G, Brummer J & Gerdtham U-G Time characteristics of the effect of alcohol cessation on the risk of stomach cancer: a meta-analysis BMC Public Health 2013; 13: 600 Saha S, Leijon M, Gerdtham U-G, Groop L, Sundquist K, Sundquist J, Winkleby M, Arvidsson D and Bennet LA culturally adopted lifestyle intervention for Middle Eastern Immigrant population at risk for diabetes: The intervention phase study protocol of MEDIM (The impact of Migration and Ethnicity on Diabetes In Malmö) Trials Ragnarson Tennvall G, Hjortsberg C, Bjarnason A, Gniadecki R, Heikkilä H, Jemec GB, Kragballe K, Miller IM & Svensson A. Treatment Patterns, Treatment Satisfaction, Severity of Disease Problems, and Quality of Life in Patients with Psoriasis in Three Nordic Countries Acta Derm Venereol 2013; 93: Kiadaliri AA, Hosseinpour R, Haghparast-Bidgoli H & Gerdtham, U-G Pure and Social Disparities in Distribution of Dentists: A Cross-Sectional Province-Based Study in Iran International Journal of Environmental Research and Public Health. 2013; 10: Axelson H, Gerdtham U-G, Ekman B, Dinh Thi Phuong Hoa and Alfvén T Inequalities in reproductive, maternal, newborn and child health in Vietnam: a retrospective study of survey data for BMC Health Services Research 2013; 12: 456 Kjellsson G and Gerdtham U-G On correcting the concentration index for binary variables Journal of Health Economics 2013; 32: Kiadaliri A.A, Jarl J, Gavriilidis G and Gerdtham U-G Alcohol drinking cessation and the risk of laryngeal and pharyngeal cancers: a systematic review and metaanalysis PLoS ONE 2013: 8(3): e58158 Kiadaliri AAK, Gerdtham U-G, Nilsson P, Eliasson B, Gudbjörnsdottir S, Steen Carlsson K Towards renewed health economic simulation of type 2 diabetes: Risk equations for first and second cardiovascular events from Swedish register data PloSOne 2013; 8(5): e62650 Kiadaliri AAK, Clarke PM, Gerdtham U-G, Nilsson P, Eliasson B, Gudbjörnsdottir S, Steen Carlsson K Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register Journal of Diabetes Research Article ID Rosberg HE, Steen Carlsson K, Cederlund IR, Ramel E, Dahlin LB Costs and outcome for serious hand and arm injuries during the first year after trauma -- a prospective study BMC Public Health 2013; 13:

9 Svensson J, Borg S & Nilsson P Costs and quality of life in multiple sclerosis patients with spasticity Acta Neurol Scand May 18 Persson S, Dahlquist G, Gerdtham UG & Steen Carlsson K Impact of childhood-onset type 1 diabetes on schooling: a population-based register study Diabetologia, 2013; 56(6): Lundqvist A, Wilking N, Gerdtham U-G, Persson U & Steen Carlsson K Johanna Lind (red.) Målriktad behandling av bröstcancer Fem rapporter om värdet av nya läkemedel. Stockholm: SNS, februari Steen Carlsson K, Berne C, Johansen P, Lanne G & Gerdtham U-G Johanna Lind (red.) Behandling av diabetes i ett hundraårigt perspektiv Fem rapporter om värdet av nya läkemedel. Stockholm: SNS, februari Lundqvist A, Norlenius Ohm A-C, Dickman P, Höglund M, Stenke L, Gerdtham U-G, Persson U, Björkholm M & Steen Carlsson K Johanna Lind (red.) Medicinska framsteg i behandling av kronisk myeloisk leukemi Fem rapporter om värdet av nya läkemedel. Stockholm: SNS, februari Norlin J M, Steen Carlsson K, Persson U & Schmitt-Egenolf M Switch to Biological Agent in Psoriasis Significantly Improved Clinical and Patient-Reported Outcomes in Real- World Practice Dermatology Published Online First: January 16, 2013 Ghatnekar O, Bondesson O, Persson U & Eriksson T Health economic evaluation of the Lund Integrated Medicines Management Model (LIMM) in elderly patients admitted to hospital BMJ Open 2013;3:e Pickwell KM, Siersma VD, Kars M, Holstein PE, Schaper NC; Eurodiale consortium. Collaborators: Prompers L, Huiberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, Holstein P, Jude E, Jirkovská A, Mauricio D, Piaggesi A, Reike H, Spraul M, van Acker K, van Baal S, van Merode F, Uccioli L, Urbancic V, Ragnarson Tennvall G. Diabetic foot disease: impact of ulcer location on ulcer healing Diabetes Metab Res Rev. 2013; 29(5): PUBLICATIONS 2012 Glenngård A & Anell A Produktivitet och patientnöjdhet i primärvården - en studie av Region Halland, Region Skåne och Västra Götalandsregionen Lund: KEFU, 2012 (Rapport 2012:2) 9

10 Glenngård AH, Hjelmgren J, Thomsen PH & Tvedten T Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway Nord J Psychiatry Dec 17. Anell A, Glenngård AH & Merkur S Sweden health system review Health Syst Transit. 2012; 14(5): Anell A, Nylinder P & Glenngård A Vårdval i primärvården: jämförelse av uppdrag, ersättningsprinciper och kostnadsansvar Stockholm: Sveriges Kommuner och Landsting, 2012 Glenngård A H Is patient satisfaction in primary care dependent on structural and organizational characteristics among providers? Findings based on data from the national patient survey in Sweden Health Economics, Policy and Law. 2012, FirstView Article, pp 1-16 Asseburg C, Willis M, Löthgren M, Seppälä N, Hakala M & Persson U Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection Schizophrenia Research and Treatment. 2012; Volume 2012, Article ID , 9 pages Anderberg S & Svensson M Vård och omsorg i hemmet för personer med multipel skleros IHE Rapport 2012:6 Svensson J, Lundberg J, Olsson P, Stjärne P & Tennvall GR Cost-effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis Prim Care Respir J. 2012; 21(4): Borg S, Näslund I, Persson U & Ödegaard K Budget impact analysis of surgical treatment for obesity in Sweden Scandinavian Journal of Surgery 2012; 101(3): Lökk J, Persson U & Wainwright M Social and Economic Benefits of Early Optimised Treatment for Parkinson s Disease Patients - Improved Quality of Life and Greater Productivity European Neurological Review 2012; 7(2): Hjalte F, Brännström J & Gerdtham U G Societal costs of hearing disorders: A systematic and critical review of literature International Journal of Audiology, 2012; 51(9):

11 Lindvall K, Astermark J, Björkman S, Ljung R, Steen Carlsson K, Persson S and Berntorp E Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy Haemophilia, 2012, publicerad online den 11 juni Persson U, Svensson J & Pettersson B. A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing. Applied Health Economics and Health Policy, 2012; 10(4): Svensson J, Ghatnekar O, Lindgren A, Lindvall O, Norrving B, Persson U & Kokaia Z Societal Value of Stem Cell Therapy in Stroke - A Modeling Study. Cerebrovascular Diseases, 2012; 33(6): Thorsén F, Rosberg H-E, Steen Carlsson K & Dahlin L B. Digital nerve injuries: Epidemiology, results, costs, and impact on daily life Journal of Plastic Surgery and Hand Surgery, 2012; 46(3-4): Ghatnekar O. & Steen Carlsson K. Kostnader för insjuknande i stroke år En incidensbaserad studie. Lund: IHE, 2012 (IHE Rapport 2012:2) Steen Carlsson K. & Persson U. Kostnader för hjärt-kärlsjukdom år 2010 Lund: IHE, 2012 (IHE Rapport 2012:1) Ghatnekar O, Ljungberg A, Wirestrand LE, Svensson A. Costs and quality of life for psoriatic patients at different degrees of severity in southern Sweden - a crosssectional study. European Journal of Dermatology Mar-Apr;22(2): Glenngård H Anna & Anell A. Vad påverkar patientupplevd kvalitet i primärvården? Stockholm : Myndigheten för vårdanalys, 2012 (Rapport 2012:1) Lundqvist A, Levin L-Å, Persson U & Steen Carlsson K Värdet av forskning och ny medicinsk teknologi för hjärt kärlsjukdom en studie utifrån exemplet ischemisk hjärtsjukdom Lund: IHE, 2012 (IHE Rapport 2012:3) Lökk J, Borg S, Svensson J,Persson U & Ljunggren G Drug and treatment costs in Parkinson s disease patients in Sweden Acta Neurologica Scandinavica 2012 Feb;125(2):

12 Norlin J M, Steen Carlsson K, Persson U & Schmitt-Egenolf M Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients British Journal of Dermatology. 2012; 166(4): Svensson, M. Prioritering av innovativa läkemedel erfarenheter inom ögonsjukvården i Danmark, Norge och Sverige. Lund: IHE, 2012 (IHE Rapport 2012:4) Anderberg EA, Steen Carlsson K, Berntorp K Use of health care resources after gestational diabetes mellitus A longitudinal case-control analysis Scandinavian Journal of Public Health Jun; 40(4): Tiberg I, Steen Carlsson K, Carlsson A, Hallström I Children diagnosed with type 1 diabetes: a randomized controlled trial comparing hospital versus homebased care Acta Paediatr Oct; 101(10): Tiberg I, Steen Carlsson K, Carlsson A, Hallström I Metabolic control, health care satisfaction and costs one month after diagnosis of type 1 diabetes: A randomised controlled trial of hospital-based care versus hospital-based home care Pediatric diabetes Jul 2 PUBLICATIONS 2011 van Battum P, Schaper N, Prompers L, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Ferreira I & Huijberts M Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation Diabet Med Feb; 28(2): Svensson M. Uppföljning Fritt val av hjälpmedel. En enkätstudie till hjälpmedelsanvändare som via Fritt val köpt hjälpmedel under perioden maj december Slutrapport. - Bilaga 6 I: Tilläggsuppdrag angående försöksverksamheten Fritt val av hjälpmedel Stockholm : Hjälpmedelsinstitutet, 2011 Persson U & Svensson M Särläkemedel - en utmaning för det värdebaserade prissättningssystemet för läkemedel IHE Rapport 2011:3 12

13 Svensson M Kostnader för nuvarande och utvidgad hälso- och sjukvård för asylsökande och papperslösa, Bilaga 2 Vård efter behov och på lika villkor en mänsklig rättighet. Betänkande av Utredningen om vård för papperlösa m.fl. Stockholm SOU 2011:48. Glenngård AH, Anell A & Beckman A Choice of primary care provider: Results from a population survey in three Swedish counties Health Policy 2011; 103(1): Glenngård AH & Ödegaard K Kostnadsanalys för hepatit B-vaccination Stockholm: Socialstyrelsen, Artikelnummer: Studien kan laddas ner som pdf eller beställas hos Socialstyrelsen Olofsson S, Wickström A, Glenngård A H, Persson U & Svenningsson A Effect of treatment with Natalizumab on ability to work in people with Multiple Sclerosis productivity gain based on a direct measurement of work capacity before and after 1 year of treatment BioDrugs 2011; 25 (5): Persson U & Ödegaard K Fetma ett ekonomiskt samhällsproblem -kostnader och möjliga åtgärder i Sverige Ekonomisk Debatt 2011; 39: Gerdtham Ulf-G, Persson U & Steen Carlsson K Värdet av nya läkemedel - en förstudie Stockholm: SNS Förlag, Hjortsberg C, Helldin L, Hjärthag F & Löhtgren M Costs for Patients with Psychotic Illness - Differences Depending on State of Remission J Ment Health Policy Econ 2011; 14(2): Hjortsberg C, Bergman A, Bjarnsson A, Heikkilä H, Hjelmgren J, Svensson Å & Tennvall Ragnarson G Are Treatment Satisfaction, Quality of Life, and Self-assessed Disease Severity Relevant Parameters for Patient Registries? Experiences from Finnish and Swedish Patients with Psoriasis Acta Derm Venereol 2011; 91: Nuijten MJ, Mittendorf T and Persson U Practical issues in handling data input and uncertainty in a budget impact analysis Eur J Health Econ. 2011; 12(3): Jarl J & Gerdtham Ulf-G Ekonomiska utvärderingar av organtransplantationer - en systematisk litteraturöversikt IHE RAPPORT 2011:2 13

14 Glenngård Häger A, Carlsson Steen K & Berglund A Ekonomiska konsekvenser av våld mot kvinnor - En kunskapsöversikt samt kostnadsberäkningar utifrån tre typfall IHE RAPPORT 2011:1 Glenngård Häger A, Carlsson Steen K & Berglund A Ekonomiska konsekvenser av mäns våld mot kvinnor - En kunskapsöversikt samt kostnadsberäkningar utifrån tre typfall. I: Att fråga om våldsutsatthet som en del i anamnesen. Uppsala: NCK-rapport 2010:4 Glenngård AH, Svensson J & Persson U Missbrukets ekonomiska börda i Sverige, Kapitel 19 Missbruket, Kunskapen, Vården. Missbruksutredningens forskningsbilaga. Delbetänkande av Missbruksutredningen. Stockholm SOU 2011:6 Eriksson M, Karlsson J, Steen Carlsson K, Dahlin LB, Rosberg HE Economic consequences of accidents to hands and forearms by log splitters and circular saws: Cost of illness study. Journal of Plastic Surgery and Hand Surgery 2011; 45(1):